Lifeline Medical Technologies

Precision Analgesia

The Active Safety Net for Inpatient Opioid Prescribing
$2.5M
Seed Round · 2026
$78.5B
Annual Opioid Economic Burden (Florence 2016)
Exhibit E
Potentially Eligible, Discretionary Abatement-Spend Category (Not Guaranteed)
46%
of Monitored Inpatients on Continuous Monitoring Had OIRD Events — Khanna et al., Anesth Analg 2020;131(4):1012-1024 (PRODIGY)
The Problem & Solution
4 Defensible Moats
Self-Assessed Non-Device CDSUnder the 21st Century Cures Act (FDA Jan 2026 CDS guidance), pending confirmatory review by regulatory counsel — a potential path to avoid the cost/timeline of regulated medical device software
Zero-PHI ArchitectureNo database. CISO-approved in weeks, not quarters
SMART on FHIR / Epic Lock-InNative EHR integration creates high switching costs at go-live
Settlement Funding WedgePoint-of-care CDS is a potentially eligible, discretionary remediation-spend category under a hospital's Exhibit E settlement allocation — subject to that hospital's own settlement administrator and state rules, not a guaranteed funding source
TAM
$6.8B*
U.S. Hospital CDS Market (illustrative estimate)
SAM
$1.4B*
Epic-Affiliated Hospitals (illustrative estimate)
ACV
$25/50/100K*
Per hospital system, by size — comp-grounded tiers (<200 / 200–500 / 500+ beds), all quotable today, plus a one-time $15–20K implementation fee
Year 3 ARR
~$2.53M*
Modeled projection — 44 hospitals at the $50K mid tier, pending Step-0 validation
Traction & Build Status
51,000+ LOC
Production codebase — TypeScript / Swift / Python
250+ ✓
iOS clinical validation scenarios passing, plus 120+ automated backend tests
iOS Beta
TestFlight deployed — physician review underway
FHIR R4
Full FHIR R4 + CDS Hooks 2.0 endpoint coverage
Epic Ready
SMART on FHIR OAuth 2.0 launch flow complete
The Ask
$2.5M
Seed · 18-Month Runway · Target Milestone: 5 Signed Hospital Contracts
30%
Engineering & Infrastructure
28%
Clinical Validation & PharmD
24%
Epic Integration & Cert.
18%
Sales, GTM & HIMSS